Delivery Order SPE2DR25D1022-SPE2DR26FQS3E
Award Date 12/16/25
Potential Completion Date 12/17/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in treating autoimmune conditions. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,156.39 and is scheduled for completion by September 5, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used to treat autoimmune conditions. This firm fixed-price delivery order has a ceiling value of $2,387.94 and is scheduled for completion by December 17, 2025. The contract was awarded competitively without a set-aside designation, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,591.96 for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, issued on December 1, 2025, with an ultimate completion date of December 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product commonly used in the treatment of autoimmune conditions. This firm fixed-price delivery order, valued at $5,023.14, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a biologic medication commonly used to treat autoimmune conditions. This firm fixed-price delivery order, valued at $1,405.04, represents a single transaction under the company's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.99 million and extends through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,598.02 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This non-competitive, firm fixed-price delivery order was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a brand-name pharmaceutical product used to treat autoimmune conditions. This firm fixed-price delivery order carries a ceiling value of $21,762.78 and is scheduled for completion by December 3, 2025. The award represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $12,360.33 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price, non-competitive set-aside contract is scheduled for completion by December 8, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a $1,591.96 delivery order to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in treating autoimmune and inflammatory conditions. This firm fixed-price contract, designated as a non-set-aside award, was executed on December 18, 2025, with an ultimate completion date of December 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child action...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed price delivery order, valued at $2,420.42, is scheduled for completion by November 19, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...